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Abstract: The introduction of a halogen atom into a small molecule can effectively modulate its 
properties, yielding bioactive substances of agrochemical and pharmaceutical interest. 
Consequently, the development of selective halogenation strategies is of high technological value. 
Besides chemical methodologies, enzymatic halogenations have received increased interest as they 
allow the selective installation of halogen atoms in molecular scaffolds of varying complexity under 
mild reaction conditions. Today, a comprehensive library of aromatic halogenases exists, and 
enzyme as well as reaction engineering approaches are being explored to broaden this enzyme 
family’s biocatalytic application range. In this review, we highlight recent developments in the 
sourcing, engineering, and application of flavin-dependent halogenases with a special focus on 
chemoenzymatic and coupled biosynthetic approaches. 
Keywords: flavin-dependent halogenases; enzyme engineering; anion promiscuity; reaction 
engineering; co-factor recycling; biocatalysis 
 
1. Introduction 
In nature, over 5000 halogenated products have been described since their first discovery over 
100 years ago including potent antimicrobial agents such as vancomycin and chloramphenicol 
(Figure 1) [1]. The incorporation of a halogen can significantly alter a molecule’s properties and may 
impact its bioactivity, metabolism, and pharmacokinetic profile [2]. As a consequence, the selective 
halogenation of small molecules is of great interest in the pharmaceutical and agrochemical industry. 
Around 20% of small molecule drugs and approximately 30% of agrochemicals are halogenated [3] 
Examples in the pharmaceutical industry include blockbusters such as rivaroxaban and 
empagliflozin with annual sales revenues in 2018 of $6.6 and $2.3 billion, respectively (Figure 1) [4]. 
Furthermore, C-X motifs are useful synthetic handles for modification of the molecule in further 
chemical steps, making halogenated species common intermediates in synthetic manufacturing 
routes [5,6]. However, chemical halogenation, even though being a well-established technology, 
suffers from the use of hazardous or even highly toxic chemicals and sometimes poor atom efficiency 
[7,8]. In addition, chemical methods often lack selectivity or have specific demands on the substrate 
structure [8,9]. Consequently, the replacement of chemical halogenation by biological means may 
offer a more selective, greener, and less dangerous process route toward molecules of industrial 
interest. 
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Figure 1. Selection of valuable halogenated agrochemicals, pharmaceuticals and natural products. 
Biocatalytic halogenation is carried out by enzymes called halogenases or haloperoxidases, 
which can be classified according to their catalytic mechanism: heme, vanadium, and flavin-
dependent halogenases follow an electrophilic mechanism, while non-heme iron halogenases 
halogenate through the formation of radical intermediates, and S-adenosyl-L-methionine (SAM) 
fluorinases react via a nucleophilic pathway [10]. This review will focus on work carried out on flavin-
dependent halogenases (electrophilic halogenases), which in contrast to heme- and vanadium-
dependent halogenases, selectively derivatize small molecules, making them especially interesting 
for applications. 
Flavin-dependent halogenases (Fl-Hals) use reduced flavin, bound in the FAD binding site of 
the enzyme, to create a C4a-hydroperoxyflavin species upon reaction with oxygen [11]. The 
generated peroxy species cannot react directly with the substrate as the flavin binding site and the 
substrate binding site are separated by an approximately 10 Å long tunnel [12–15]. Instead, crystal 
structures of flavin-dependent halogenases show the presence of a chloride binding site near the 
flavin binding site [15,16], and mechanistic studies suggest that a nucleophilic attack of the chloride 
on the peroxyflavin may create hypohalous acid (HOX) [11]. The hypohalous acid then travels to the 
substrate binding site and is believed to interact with an active site lysine either by reaction or via 
hydrogen bonding (Figure 2) [16,17]. It is assumed that this electrophilic chlorine species is 
responsible for electrophilic aromatic substitution of the proximally bound substrates. Notably, an 
active site glutamate residue has also been found important for catalysis; however, its precise role in 
the reaction mechanism still remains debated [2,18]. 
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Figure 2. Reaction mechanism of flavin-dependent halogenases. Reduced flavin reacts with oxygen 
to form a peroxyflavin species, which in turn reacts with a halide ion, generating free hypohalous 
acid. The hypohalous acid travels through an approximately 10 Å tunnel before reacting with an 
active site lysine. Through an electrophilic aromatic substitution mechanism, the halogenated 
aromatic compound is formed. 
2. Enzyme Diversity and Substrate Scope 
To date, a plethora of flavin-dependent halogenases (Fl-Hals) has been identified. Fl-Hals accept 
a range of different substrates but preferentially have been found to halogenate L-tryptophan 
(Figure 3: red square) [19], pyrrole-like compounds (Figure 3: green triangle) [20], phenolic 
compounds (Figure 3: blue circle) [21], and indole (Figure 3: orange square) [22]. In this section, we 
will give an overview of the natural diversity of flavin-dependent halogenases emphasizing the 
recently discovered members of this enzyme family. 
The first flavin-dependent halogenases were identified in the mid-1990s [19,23]. PrnA, 
discovered in Pseudomonas fluorescens in 1998, is for example involved in the biosynthesis of 
pyrrolnitrin, a secondary metabolite derived from L-tryptophan with a strong antifungal activity [19]. 
PrnA catalyzes the chlorination at the 7-position of the indole moiety of L-tryptophan (Product 
Type I, Figure 3). Following this discovery, research intensified and many additional L-tryptophan 
Fl-Hals (Trp-Fl-Hals) were described [19,24–27]. The widely applied 7-tryptophan halogenase RebH, 
for example, stems from the bacterium Lechevalieria aerocolonigenes and its natural function is the 
chlorination of precursors of the antitumor agent rebeccamycin [24]. Another Fl-Hal able to 
halogenate at the 7-position is KtzQ found in Kutzneria sp. 744 [26]. This halogenase is involved in 
the biosynthesis of Kutzneride, an antifungal nonribosomal hexadepsipeptide. After chlorination at 
the 7-position, tryptophan is further chlorinated at the 6-position by KtzR, which has a ∼120-fold 
preference for 7-Cl-L-Trp over L-Trp [26]. Other halogenases have a natural preference to chlorinate 
at the 6-position of L-Tryptophan, such as Thal from Streptomyces albogriseolus [25] and a thermophilic 
tryptophan halogenase (Th-Hal) found in Streptomyces violaceusniger [28]. Furthermore, SttH found 
in Streptomyces toxytricini [29] and the recently identified halogenases in Saccharomonospora sp.  
CNQ-490 (Tar14) [30], as well as a halogenase found through metagenomic screening of soil samples 
from the Anza-Borrego desert (BorH) [31] are able to chlorinate and brominate at the 6-position of 
this aromatic amino acid. The 5-position of the indole moiety of tryptophan can be modified by PyrH 
from Streptomyces rugosporus [27], SpmH from Streptomyces sp. SCSIO 03032 [32] and XszenFHal 
identified in Xenorhabdus szentirmaii [33]. Recently, a novel set of flavin-dependent halogenases called 
BrvH [22], xcc-b100_1333, xcc-b100_4156, and xcc-b100_4345 [34] were described. These enzymes 
were found to have a high sequence identity to known Trp-Fl-Hals, but could not convert L-
tryptophan. This property was ascribed to the fact that certain amino acids required to stabilize 
tryptophan within the active site pocket were missing [22,34]. Instead, these halogenases can accept 
smaller substrates such as indole (Product Type III, Figure 3), which triggered us to name these 
enzymes “Indole Fl-Hals” in the frame of this review, and prefer bromination over chlorination. BrvH 
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was found in Brevundimonas BAL3, whereas the three xcc-b100 enzymes stem from Xanthomonas 
campestris (Xcc). The plant pathogen Xcc belongs to a group of Proteobacteria that is known to infect 
over 350 plant species by secreting a characteristic yellow pigment called xanthomonadin, a mixture 
of brominated aryl polyene esters. Finally, in 2019, a viral halogenase, named VirX1, was discovered 
in a cyanophage and was shown to act on 6-azaindole (Product Type II, Figure 3) [35]. 
 
Figure 3. Phylogenetic tree depicting a selection of flavin-dependent halogenases and their native 
products. The tree was constructed using the maximum likelihood method, a bootstrap of 1000, with 
the alignment based on amino acids by MEGAX [36] and MUSCLE [37]. Branches corresponding to 
partitions reproduced in less than 50% of bootstrap replicates are collapsed. 
Today, the biocatalytic toolbox contains flavin-dependent halogenases that can convert 
molecules beyond L-tryptophan derivatives. PrnC and PltA found in Pseudomonas fluorescens, for 
example, convert pyrrole-like substrates [19,20]. While PltA requires its substrate to be tethered to a 
carrier protein [20], PrnC acts on a free-standing intermediate in the biosynthesis of pyrrolnitrin. 
After the PrnA catalyzed chlorination of L-tryptophan to form 7-chloro-L-tryptophan (vide infra), 
which is followed by a ring rearrangement and a decarboxylation step, PrnC chlorinates the 3-
position of the pyrrole ring to form aminopyrrolnitrin (Product V, Figure 3) [19]. Phenols are an 
additional molecule class that is known to be converted by halogenases such as Rdc2, RadH, Bmp5, 
and ChlA [38–41]. Phenolic halogenases typically originate from fungi except for PltM, which was 
isolated from Pseudomonas fluorescens Pf-5 [42]. Initially, PltM was identified as one of three putative 
halogenases encoded in the biosynthetic gene cluster of pyoluteorin (one of the others being PltA), 
an antifungal compound containing a dichloropyrrole moiety [42]. Almost twenty years later, it was 
shown that PltM catalyzes mono- and di-chlorination of phloroglucinol (Product Type VI, Figure 3), 
yielding a compound that serves as a transcriptional factor of the pyoluteorin biosynthesis rather 
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than a biosynthetic intermediate [43]. MalA’, a rather unusual halogenase from Malbranchea 
graminicola, can act on the bulky molecule premalbrancheamide (Product Type VII, Figure 3) [44]. 
Except for the very electronegative fluoride ion, flavin-dependent halogenases have been shown 
to introduce all common halides into small molecules. However, certain anion preferences exist: The 
well described Trp-Fl-Hals RebH, Thal and PyrH prefer chlorination over bromination [24,25,27], 
while BrvH and VirX1 prefer bromination over chlorination [22,35]. For the three xcc-b100 enzymes, 
no chlorination was observed, and iodination was only found for Bmp5, PltM, and VirX1 [34,35,40,45] 
(Table 1). 
Looking forward, the discovery of flavin-dependent halogenases with alternative substrate 
preferences will be fueled by the rapidly expanding amount of genetic information available from 
public databases. As gene synthesis is becoming more cost effective and high throughput assays are 
being established, putative halogenases can be verified quickly in an experimental setup. In a recent 
study from Fisher et al. [46], the authors used a genome mining approach to identify 128 putative Fl-
Hals. By co-expression with the chaperones GroES and GroEL, 87 halogenase candidates were 
obtained in sufficient soluble amounts for the later analysis via high throughput LC-MS analysis 
(11 s/analysis). The soluble enzymes were screened towards electron rich substrates known to be 
commonly converted by Fl-Hals, as well as more complex substrates. With this approach, 39 new Fl-
Hals were identified, some of which showed halogenation of complex compounds, offering 
advantageous starting points for further evolution [46]. 
Table 1. Halide versatility of Fl-Hals. 
Enzyme Halogen (X) Literature  
RebH Cl > Br [24]   
Thal Cl > Br [25]  
PyrH Cl > Br [27]  
KtzQ Cl [26]  
PrnA Cl [19]  
Th-Hal Cl, Br [47]  
KtzR Cl [26] Tryptophan-Fl-Hal 
SttH Cl, Br [29]  
Tar14 Cl, Br [30]  
SpmH Cl, Br [32]  
XszenFHal Cl, Br [33]  
BorH Cl, Br [31]  
BrvH Cl < Br [22]   
xcc-b100-4156 Br [34]  
xcc-b100-1333 Br [34] Indole-Fl-Hal 
xcc-b100-4345 Br [34]  
VirX1 Cl < Br < I [35]   
Bmp5 Br, I [40]   
ChlA Cl [41]  
PltM Cl, Br, I [45] Phenolic-Fl-Hal 
RadH Cl [39]  
Rdc2 Cl, Br [21]  
PrnC Cl [19]   
PltA Cl, Br [20] Pyrrole-Fl-Hal 
MalA Cl, Br [44]   
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3. Cofactor and Reaction Engineering 
As can be deduced from the reaction mechanism (Figure 2), flavin-dependent halogenases 
require a constant supply of reduced FADH2 to function. In nature, the oxidized flavin species is 
reduced by a flavin reductase (Fre). In the case of halogenase RebH, for example, the corresponding 
flavin reductase called RebF was identified in the native organism Lechevalieria aerocolonigenes [24]. 
Likewise, a flavin halogenase–flavin reductase pair, PrnA and PrnF, was identified in Pseudomonas 
fluorescens. For in vitro studies of halogenases, however, alternative flavin reductases may be used. 
Examples comprise a thermophilic Fre from Bacillus subtilis WU-S2B [47], a Fre from Pseudomonas 
fluorescens [22], or a Fre from the Escherichia coli strain K12 [33]. Flavin reductases employ NADH to 
reduce flavin; therefore, biocatalytic applications may include an additional enzyme for the reduction 
of NADH such as a glucose dehydrogenase (GDH) (Figure 4) or an alcohol dehydrogenase (ADH). 
By adding the necessary auxiliary enzymes (Fre and GDH or ADH), halogenation biocatalysis 
reactions can run on the inexpensive substrate glucose or isopropanol, while the cost intensive 
cofactors FAD and NAD+ are recycled. 
 
Figure 4. For the regeneration of FADH2, which is needed for the production of the reactive species 
hypohalous acid, two auxiliary enzymes can be used: a flavin reductase (Fre) for the reduction of FAD 
and a glucose dehydrogenase for the reduction of NAD+. Overall, the co-substrate glucose is used in 
excess, whereas the more expensive cofactors FAD and NAD+ can be recycled. 
Despite the described advantages, the introduction of a cofactor-recycling system renders the 
biocatalytic reaction more complicated, less robust, and harder to scale-up. Consequently, several 
studies addressing the drawbacks of cofactor regeneration have been carried out. Andorfer et al. 
constructed a fusion protein of a flavin halogenase and a reductase by linking the enzymes RebH and 
RebF. Interestingly, the fusion construct showed higher product titers in vivo for native and non-
native substrates than the co-expression of the individual enzymes [48]. Furthermore, the authors 
suggested that the creation of the fusion protein could simplify evolution assays because the 
reductase must not be regularly prepared and purified. Following an alternative strategy, Frese and 
Sewald linked a halogenase and the auxiliary enzymes after translation by employing the 
bifunctional chemical glutaraldehyde. In their study, the authors overexpressed RebH (Fl-Hal), PrnF 
(Fre), and an alcohol dehydrogenase (use of isopropanol instead of glucose for the regeneration of 
NAD+) individually and subsequently crosslinked the three enzymes to so-called combi cross-linked 
enzymes aggregates (combiCLEAs) (Figure 5) [49]. By creating combiCLEAs, the system could be 
reused at least ten times and stored for several months, whereas the purified free RebH showed a 
considerable loss in activity after being stored for 12 weeks at 4 °C [49]. 
  
Catalysts 2019, 9, 1030 7 of 21 
 
Figure 5. Bromination of L-Trp using RebH cross-linked with the auxiliary enzymes PrnF and ADH 
(combi cross-linked enzymes aggregates (combiCLEAs)). 
Going beyond traditional co-factor recycling schemes, Schroeder et al. showed that the need for 
auxiliary enzymes can be entirely overcome by using EDTA and light for the regeneration of FADH2 
(Figure 6). In their study, the authors reduced enzyme bound FAD with EDTA as the sacrificial 
electron donor and light at 450 nm. In this way, 58% of a 0.5 mM L-Trp solution was chlorinated 
within 25 h by using the flavin halogenase PyrH. Although the light driven cofactor recycling 
approach had a clearly lower turnover frequency (0.72 h−1) compared to the enzymatic regeneration 
(3.0 h−1), this study described the production of chlorinated compounds by applying only light, halide 
salt, air, and FADH2 in aqueous solution [50]. 
 
Figure 6. Chlorination of L-Trp by applying the flavin-dependent halogenase PyrH, EDTA, and 
light. 
Another approach to circumvent the use of auxiliary enzymes was developed by Ismail et al. 
[51]. Employing a set of three tryptophan halogenases (PyrH, Thal, and RebH) in combination with 
an NADH mimic for FAD+ reduction, L-tryptophan could be selectively halogenated at the 5-, 6-, or 
7-position of the indole moiety, respectively (Figure 7). Notably, the biocatalysis reactions using the 
NADH mimic showed a 3.5–4.7 times faster initial rate compared to the enzymatic cofactor 
regeneration system [51]. 
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Figure 7. Chlorination of L-Trp using different Fl-Hals (PyrH, Thal, and RebH) applying an NADH 
mimic for the regeneration of FAD. 
4. Strategies to Scale-up Biocatalytic Aromatic Halogenations 
Flavin-dependent halogenases selectively install halides into small molecules under mild 
reaction conditions, thus providing a promising green alternative to the often toxic catalysts used in 
traditional organic halogenations. However, restrictions associated with the biocatalytic approach 
such as low expression yields and limited stability of the enzymes, as well as a narrow substrate scope 
currently still hinder industrial application. In order to broaden the application potential of flavin-
dependent halogenases, several studies addressing the above enumerated drawbacks have been 
carried out in the last decade. 
4.1. Protein Overexpression and Stabilization 
The first attempt to upscale enzymatic halogenation was carried out by the group of Lewis [52]. 
In this study, the authors increased the expression level of the soluble halogenase RebH on a scale 
sufficient for preparative biocatalysis. Co-expression of chaperones (GroEL and GroES) in tandem 
with cell culture condition optimization led to a 10-fold increase of enzyme concentration in E. coli 
(111 mg L−1) compared to previously reported values [24]. In the same study, a regeneration system 
utilizing glucose dehydrogenase (GDH) together with a fusion protein of reductase RebF and maltose 
binding protein (MBP) for preparative scale reactions (10 mg) was developed. High halogenation 
yields were observed for the transformation of several non-natural bioactive substrates including 
indoles and naphthalenes highlighting the synthetic utility of the enzyme (Figure 8). In order to 
explore the accessible synthesis scale, 100 mg of L-tryptophan were used as a substrate for 
chlorination by crude cell lysate of RebH. Although the substrate was not fully converted, the enzyme 
remained active under these conditions, and a 69% final yield could be obtained [52]. 
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Figure 8. Product structure and isolated yields of preparative scale RebH catalyzed halogenation. 
HPLC conversion yields are shown in brackets. 
The preparative efficiency of RebH has also been explored by Frese and Sewald who developed 
a multifunctional biocatalytic system exploiting the technique of cross-linked enzyme aggregates 
(combiCLEAs, vide infra). Using this enzymatic preparation, complete bromination of L-tryptophan 
was achieved after eight days, and 1.813 g of L-7-bromotryptophan TFA were isolated in high purity 
(isolated yield 92%). CombiCLEA formation was found to increase significantly the long-term 
stability of RebH, thus facilitating the enzymatic regioselective halogenation for gram scale synthesis 
[49]. In the same manner, the Micklefield group halogenated non-natural substrates such as 
anthranilamide and tryptophol using CLEAs of four different Fl-Hals as the first step of a 
chemoenzymatic reaction [5]. 
The instability of flavin-dependent halogenases in certain reaction conditions has also been 
addressed by directed evolution. The Lewis group was among the first to generate a thermostable 
halogenase variant by employing three rounds of error prone PCR and recombinations. The obtained 
RebH variant, which contained eight mutations, was characterized by an 18 °C increased melting 
temperature compared to the wildtype enzyme. However, the catalytic efficiency of the mutant was 
significantly decreased at 21 °C owing to a lower conformational flexibility of the enzyme [53]. 
Exploiting a high throughput assay for rapid library screening, Schnepel et al. also evolved 
thermostable flavin-dependent halogenases. In their study, a doubly mutated variant was found with 
a 10 °C increase of its Tm compared to the wildtype enzyme. Unlike the wildtype enzyme, which 
significantly lost its activity after 2–3 h of incubation at 40 °C, the new variant, named Thal-GR, 
remained active even after 6 h of incubation at this temperature. In addition to the increased catalyst 
stability, the specific activity of the mutant Thal-GR was also 2.5 times higher than that of the 
wildtype [54]. Based on these results, the same group published a comprehensive study to further 
improve the thermostability of the generated variant Thal-GR three years later. Combining different 
mutagenesis strategies, the authors identified seven variants with higher thermostability compared 
to the native enzyme. A variant called Thal-GLV exhibited a good stability-activity relationship as it 
showed a significant increase in thermostability (ΔΤ50 = 16 °C, ΔΤm = 23.5 °C) compared to the 
wildtype, while exhibiting a 2.4-fold increase in activity at 25 °C. The stabilizing effect of the 
mutations has been linked to an increased association of the halogenase monomers to form 
homodimers in solution. Moreover, a crucial site with a strong effect on substrate selectivity was also 
identified. The single mutant Thal-S359G showed a distinct preference towards L-tryptophan, and 
only 17% bromination of D-tryptophan was observed compared to >99% in the case of the wildtype 
enzyme [55]. In a complementary approach to identify thermostable halogenases, the Micklefield 
group identified a thermophilic tryptophan halogenase (Th-Hal) from a thermophilic and 
halotolerant strain of Streptomyces via computational genome mining. The newly discovered 
thermostable flavin halogenase was characterized by an approximately 10 °C higher melting 
temperature (Tm = 47.8 °C) than other known Fl-Hals such as RebH, SttH, PrnA, KtzR, and PyrH. 
Combining this thermostable enzyme with a thermophilic flavin reductase (Th-Fre) from Bacillus 
subtilis WU-S2, the authors established a more efficient and robust biocatalytic system that led to 74% 
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conversion of a 0.5 mM solution of tryptophan at 45 °C in contrast to other known halogenases, which 
gave significantly lower conversions (around 40% for PyrH) using the same reaction conditions [47]. 
4.2. Substrate Scope and Regioselectivity 
To assess the substrate scope of flavin-dependent halogenases, Frese et al. showed that RebH 
can halogenate substrates beyond the native L-tryptophan such as C-5- and C-6-substituted fluoro-, 
amino-, chloro-, hydroxy-, and methyl-tryptophans [56]. Subsequently, Shepherd et al. successfully 
submitted the non-indolic substrates kynurenine, anthranilamide, anthranilic acid, and other anilines 
to the regiocomplementary tryptophan halogenases PyrH and PrnA highlighting that also these 
enzymes possess substrate promiscuity, which can be exploited in applications (Figure 9) [57]. 
 
Figure 9. Non-indolic substrates accepted for chlorination. X: PyrH halogenation site, Y: PrnA 
halogenation site. 
The Tsodikov group investigated the accepted substrate spectrum of the halide versatile 
phenolic halogenase PltM. The authors found that PltM can halogenate several small phenolic and 
aniline derivatives. Encouraged by these findings, the study was successfully continued towards 
more bulky compounds including FDA approved drugs and natural products such as terbutaline, 
fenoterol, resveratrol, and catechin (Figure 10) [45]. Notably, no halogenation activity was observed 
in the case of a nitrobenzene derivative due to the strongly electron withdrawing nitro group that 
prevented the halogenation of the substrate. 
Tailoring the substrate scope of enzymes towards desired molecules has also been approached 
through protein engineering. Interestingly, even enzymes exhibiting very little initial substrate 
promiscuity could be altered in this way. Following a substrate walking approach, Payne et al., for 
example, extended the substrate scope of the natural tryptophan halogenase RebH towards the 
significantly larger biologically active compounds yohimbine and carvedilol (Figure 11). Starting 
with a thermostable mutant of RebH (1-PVM), the authors performed three rounds of random 
mutagenesis and screening and could generate variants that selectively halogenate a number of 
unnatural substrates with a range of sizes, substitutions, and biological activities. Although the 
majority of the beneficial mutations were found close to the active site, a crucial mutation (A442V) 
was located distal to the active center. This finding highlights the worth of random mutagenesis in 
directed evolution strategies as this technique may identify amino acid positions that are difficult to 
predict via rational design strategies [58]. 
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Figure 10. FDA approved drugs (terbutaline, fenoterol) and natural products (resveratrol, catechin) 
accepted by the phenolic halogenase PltM [45]. 
Enzyme engineering has also been employed to alter the regioselectivity of halogenases in order 
to control the site of halogenation in small molecules. In a first example of this approach, the structure 
of PrnA, a tryptophan 7-halogenase, was analyzed, and three aromatic residues around the enzyme’s 
active site were mutated to alanine. One identified variant, F103A, was found to halogenate both at 
the C7 and C5 position of the tryptophan indole ring exhibiting a 2:1 ratio of the products. The 
exchange of the large amino acid phenylalanine with the smaller alanine allowed the substrate to 
adopt its “native” orientation but also bind in a similar mode as in the tryptophan 5-halogenase PyrH 
[59]. In a similar manner, structure guided mutagenesis was employed by Shepherd et al. in 2016 to 
alter the regioselectivity of tryptophan 6-halogenase SttH. The generated triple mutant SttH 
L460F/P461E/P462T transformed 75% of the supplied tryptophan into the C5-halogenated product, 
whereas the wildtype enzyme exhibited almost the same activity towards the C6-halogenated 
product [60]. In the same year, Lewis and co-workers published a thorough study in which RebH 
was engineered for altered regioselectivity. High throughput MALDI-MS analysis was used to screen 
the transformation of deuterium substituted probe substrates. Utilizing a previously evolved variant, 
which was able to chlorinate tryptamine with 99% selectivity towards the C7 position, the authors 
identified two variants, named 8F and 10S, which could selectively chlorinate tryptamine at the C6 
and C5 site, respectively. Additional reverse mutations (mutations that lead to the initial starting 
sequence) proved beneficial for the enzymes activity while maintaining the achieved selectivity [61]. 
In a structure-based protein engineering approach, Moritzer et al. substituted five residues in the 
substrate binding site of Thal by the corresponding amino acids of the closely related tryptophan 
halogenase RebH to switch regioselectivity from the 6- to 7-position. The resulting variant, named 
Thal-RebH5, exhibited a 95% change in regioselectivity towards C7-halogenation for both 
chlorination and bromination of L-tryptophan, further confirming the importance of the binding pose 
of the substrate for the regioselectivity outcome [62]. Building on previous learnings, Payne et al. 
recently reported the first enantioselective desymmetrization of methylenedianinelines catalyzed by 
engineered RebH variants. Docking simulations and structure guided mutagenesis afforded mutants 
with improved activity and altered selectivity [63]. 
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Figure 11. RebH catalyzed halogenation of various substrates indicating the isolated product yields 
and conversion yields (in brackets). a Multiple closely eluting products were observed and were not 
individually isolated. 
4.3. Biosynthetic Pathways 
Fueled by the discovery of novel halogenases with interesting properties, the incorporation of 
halogenases into biosynthetic pathways has become an attractive tool to increase the diversity of 
accessible products and to synthesize bioactive molecules or valuable intermediates. 
In 2010, Roy et al. carried out the first introduction of a halogenase gene into a synthetically 
unrelated pathway. In their study, the authors complemented the biosynthesis of the uridyl peptide 
antibiotic (UPA) pacidamycin from Streptomyces coeruleorubidus with the prnA gene expressing the 
tryptophan 7-halogenase PrnA. The resulting strain could produce the “unnatural” 
chloropacidamycin in a yield of 1 mg per liter culture with a ratio to its non-chlorinated analogue as 
high as 4:1. The installed chlorine then served as a handle, enabling the selective chemical 
functionalization of the antibiotic to yield a variety of derivatives [64]. Today, halogenase genes have 
also been integrated into medicinal plant metabolisms in order to produce chlorinated indole 
alkaloids with altered and/or improved pharmacological properties. Two prokaryotic halogenase 
genes encoding 7-tryptophan halogenase RebH or 5-tryptophan halogenase PyrH together with RebF 
as the partner reductase were introduced into Catharanthus roseus. It was reported that both 
halogenases function productively in the plant cell environment leading to the formation of the 
corresponding halotryptophans (7- or 5-halotryptophan), which subsequently enter the metabolic 
pathway of the plant cells to form chlorinated indole alkaloids. However, the efficiency of tryptophan 
decarboxylase, an enzyme that converts tryptophan to tryptamine, was significantly lower towards 
the halogenated substrates. This led to an accumulation of substantial levels of a non-natural 
intermediate, which had an adverse effect on the morphology and the growth rate of tissues [65]. To 
overcome this negative outcome, Glenn et al. employed site directed mutagenesis to generate a RebH 
mutant, which preferentially halogenates tryptamine rather than the native substrate tryptophan. 
Using this approach, the accumulation of 7-chlorotryptophan and its negative effect on the cell 
metabolism could be bypassed [66]. 
The potential application of plants as platforms for the manufacture of rare and valuable 
halogenated products has been also studied by Fräbel et al. Tryptophan 6-halogenase from 
Streptomyces toxytricini SttH has been successfully integrated into tobacco plants allowing the 
formation of chlorotryptophan in the cytosol when co-expressed with the flavin reductase RebF. The 
introduction of an additional flavin-dependent halogenase (RebH) into the metabolic setup of the 
plant led to the formation of 6,7-dichlorotryptophan, while a novel precursor of monoterpenoid 
indole alkaloids, 6-chlorotryptamine, was observed when SttH was co-expressed with tryptophan 
decarboxylase (TDC). Notably, SttH and RebH remained active even in the absence of the partner 
reductase when localized in chloroplasts, indicating the presence of sufficient reduction equivalents 
in these organelles for halogenation reactions [67]. 
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Following a combinatorial biosynthesis approach, Wang et al. combined enzymes from different 
sources in Escherichia coli to generate valuable compounds. Using a multiple vector system, the fungal 
Fl-Hal Rdc2 was co-expressed with tyrosine ammonia-lyase (TAL), 4-coumarate:CoA ligase (4CL), 
and stilbene synthase (STS), resulting in a novel chlorinated derivative in addition to resveratrol. This 
novel compound was identified as 2-chloro-resveratrol highlighting the broad substrate scope of 
Rdc2 [68]. 
4.4. Chemoenzymatic Synthesis 
Chemoenzymatic synthesis has proven to be a powerful tool for the manufacture of complex 
compounds offering numerous advantages such as higher yields, decreased costs, environmental 
benefits, and high selectivity compared to purely chemical strategies [69]. In this context, the site-
specific enzymatic halogenation of natural products can provide halogenated compounds that are of 
interest for the further functionalization by cross-coupling chemistry. The combination of chemo- and 
enzyme catalysis can thus lead to the formation of C-C, C-N, C-F, and C-O bonds from C-H positions, 
which were beyond the scope of chemocatalytic activation chemistry. 
Chemical modification through Pd catalyzed cross-coupling of a biosynthetically halogenated 
natural product has been reported by the group of Goss. Employing mild reaction conditions to 
account for the thermal instability of the substrate chloropacidamycin, the authors obtained various 
7-aryl-pacidamycin derivatives in high yields. This functionalization approach could not only be 
applied on purified natural compounds, but also worked when using crude extracts of the 
halogenated substrates [64]. 
In a similar manner, Pd catalyzed Suzuki–Miyaura cross-coupling (SMC) reactions have been 
adopted by the O’Connor group to synthesize aryl and heteroaryl analogues of monoterpene indole 
alkaloids. Exploiting the technique of mutasynthesis in C. roseus hairy root cultures, the authors 
introduced a chemical halogen handle into the indole moiety of the monoterpene indole alkaloids 
followed by the subsequent chemical derivatization using the crude cell extracts. Based on their 
promising results, the authors further scaled up the cross-coupling reactions using 16 g of the crude 
hairy root extract to obtain milligram quantities of three alkaloid analogs [70]. Durak et al. further 
expanded the application scope of the chemoenzymatic strategy by derivatizing non-native bioactive 
small aromatic molecules such as carvedilol, pindolol, thenalidine, and tryptoline and its derivatives. 
Two RebH variants, 3-SS and 4-V, were used for the selective halogenation of the aforementioned 
compounds followed by subsequent Pd catalyzed cross-coupling reactions with boronic acids, 
amines, and trifluoroethanol on the crude biocatalysis extracts to generate new C-C, C-N, and C-O 
bonds [71]. 
Although the advantages of chemoenzymatic reactions for the synthesis of demanding and 
complex compounds has been successfully demonstrated, the detrimental effects of protein 
contaminants on the metal catalyst require an intermediate extraction step of the halogenated 
precursor that limits process scale-up. To address this challenge, the group of Sewald utilized 
combiCLEAs of several Fl-Hals in a single pot approach [72]. In this study, a bromine substituent was 
introduced biocatalytically at the C5, C6, or C7 position of L-tryptophan on a preparative scale. After 
filtration of the biocatalyst, a SMC reaction led to an efficient modification of the halogenated 
compounds, and the resulting cross-coupling product could subsequently be Boc protected and 
purified for further applications. This three-step one pot approach is an important proof-of-concept 
for the development of more sustainable and consecutive biohalogenation-chemocatalytic cross-
coupling processes. 
Latham et al. further simplified the one pot halogenase-SMC cascade by separating the protein 
from the Pd catalyst using polydimethylsiloxane membranes (PDMS). Compartmentalization was 
achieved thanks to the hydrophobic nature of the PDMS membranes, which allowed for the diffusion 
of non-polar compounds such as substrates and intermediates while the diffusion of polar 
compounds (enzymes, Pd catalysts, and cofactors) was prevented (Figure 12). Combining this 
method with halogenase CLEAs led to higher concentrations of the aryl halide and reduced Pd 
loading (2 mol%) compared to free pure protein reactions (Pd loading: 10 mol%) [5]. 
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Figure 12. Polydimethylsiloxane (PDMS) compartmentalization. PDMS membrane permits diffusion 
of non-polar compounds (substrates, intermediates), while polar compounds such as enzymes, Pd 
catalysts, and cofactors are blocked. This compartmentalization overcomes the incompatibility of the 
enzyme and transition metal that reduces the efficiency of the chemoenzymatic process. Figure 
adapted from [5]. 
Further pioneering the one pot chemoenzymatic reactions, the Goss group combined synthetic 
biology with synthetic chemistry. After an optimization of the cultivation media of the engineered 
strains to minimize the impact of media components on the cross-coupling efficiency, the authors 
developed a biological system for the generation of brominated metabolites that can synchronously 
be modified through cross-coupling in living cultures (Figure 13). This approach provides the 
advantage of a simplified product isolation and a continuously producing biosynthetic system [6]. 
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Figure 13. In culture biosynthesis and cross-coupling of Br-pacidamycin-D. The engineered strain of 
S. coelicolor RG-1104 grown in the presence of sodium bromide is able to produce Br-pacidamycin-D. 
The brominated compound is subsequently modified through Pd catalyzed Suzuki−Miyaura cross-
coupling reactions under mild conditions. 
5. Conclusion 
The selective halogenation of small molecules is of high interest for many industries and is 
especially sought after in the pharmaceutical industry and agrochemistry [2,3]. Today, biocatalytic 
halogenations are promising tools for the preparation of small quantities of selectively derivatized 
products (Table 2), which can be used in medicinal chemistry, or serve as intermediates for the total 
synthesis of complex molecules (Chapter 4.4). However, to our knowledge, more than a gram 
quantity of halogenated target compound has not yet been prepared (Table 2), illustrating two of the 
current challenges in aromatic halogenase catalysis: the enzymes suffer from low productivity and 
limited scalability. Thus, in order to expand the application scope of flavin-dependent halogenases, 
further studies aimed to broaden the substrate scope and increase the robustness of these enzymes 
are required. These can entail bioinformatic studies to identify additional members of the flavin-
dependent halogenase superfamily with an extended substrate scope [46] or higher thermostability 
[47]. Additionally, approaches such as the “catalophore” strategy might be successful in the 
identification of novel flavin-dependent halogenases [73]. In this bioinformatic method, Steinkellner 
et al. carried out a structure guided search for the discovery of ene-reductases by predicting enzyme 
activity based on three-dimensional constellations of functional groups. 
Following the discovery of promising wildtype enzymes, engineering strategies that should 
equally consider enzyme stability and activity will, at least to some extent, inform about the structure-
function relationship in flavin-dependent halogenases. In this respect, in silico design based on 
energy functions might be a very valuable tool, as methods such as Rosetta_ddg and FireProt have 
been proven to optimize protein structures successfully [74–78]. The obtained knowledge may then 
lead to the development of tailored enzyme variants, which through their increased stability, activity 
and, robustness may facilitate industrial usage. Looking forward, engineering flavin-dependent 
halogenases towards the acceptance of more electron poor substrates [79] through increasing the 
electrophilicity of the halogenating species will be a way to further enhance their applicability. As 
proposed by Latham et al., reaction engineering aspects, such as optimizing oxygen concentration in 
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the reaction medium and the management of the level of reactive oxygen species could be further 
levers to increase flavin-dependent halogenase productivity [2]. 
Table 2. Examples of preparative scale applications of flavin-dependent halogenases. 
Enzyme Scale (mg) Substrate Halogen Insertion 
Conversion 
Yield %/Isolated product 
yield % 
Ref. 
PyrH 
(combiCLEAs) 
 
PyrH and SttH 
(combiCLEAs) 
 
RebH 
(combiCLEAs) 
136 
 
 
15 
 
 
24 
Anthranilamide 
 
 
3-Indolepropionic acid 
 
 
Tryptophol 
Br 
 
n.d. [a] [5] 
Th-Hal (purified) 
16 
18 
17 
16 
11 
11 
L-tryptophan 
1-methyl-L-tryptophan 
5-hydroxy-L-tryptophan 
L-kynurenine, 
Anthranilic acid 
Anthranilamide 
Cl 
-/62.5 
-/12 
-/16 
-/21 
-/8 
-/19 
[47] 
RebH 
(combiCLEAs) 
1000 
40 
40 
L-tryptophan 
D-tryptophan 
L-5-hydroxytryptophan 
Br 
100/- 
57 / 
53 / 
[49] 
RebH (purified) 
 
RebH (purified) 
 
 
 
 
 
 
 
 
 
 
 
RebH (lysate) 
10 
 
10 
 
 
 
 
 
 
 
 
 
 
 
100 
L-tryptophan 
 
D-tryptophan 
Tryptamine 
N-Ω-methyltryptamine 
Tryptophol 
2-methyltryptamine 
5-methyltryptamine 
2,3-disubstituted indole tryptoline 
Indole 
2-aminonaphthalene 
1-naphthol 
 
L-tryptophan 
Cl 
 
Br 
Cl 
 
 
 
 
 
 
 
 
 
 
Cl 
94/74 
97/85 
99/78 
98/53 
65/65 
95/95 
96/60 
99/58 
58/54 
64/53 
98/93 
95/59 
 
 
74/69 
[52] 
RebH (purified) 10 
L-tryptophan 
2-methyltryptamine 
2-aminonaphthalene 
Tryptoline 
Cl 
-/69 
-/56 
-/62 
-/67 
[53] 
PyrH 
(combiCLEAs) 
 
Thal 
(combiCLEAs) 
 
RebH 
(combiCLEAs) 
50 
 
 
50 
 
 
150 
L-tryptophan 
 
 
L-tryptophan 
 
 
L-tryptophan 
Br 
-/76 
 
 
-/61 
 
 
-/84 
[54] 
 
SttH 
(combiCLEAs) 100 Anthranilamide Cl -/25 [60] 
RebH variants 
0S/8F/10S 
(purified) 
10 Tryptamine 
 
Cl 
 
98/73/78 [b] [61] 
Thal-RebH5 
variant (lysate) 
30 L-tryptophan 
Cl 
Br 
30/- 
15/- 
[62] 
RebH variant 4-V 
(purified) 
10 t-Bu dianiline methane Cl 80/- [63] 
Catalysts 2019, 9, 1030 17 of 21 
RebH variant 3-SS 
(purified) 
 
 
 
RebH variant 4-V 
(purified) 
 
10 
 
 
 
 
10 
Tryptoline 
Eleagnine 
Pinoline 
Tetrahydroharmine 
 
Debromodeformylflustrabromine 
Yohimbine 
Pindolol 
Carazolol 
Carvedilol 
Cl 
 
 
 
 
Cl 
-/78 
-/83 
-/80 
-/79 
 
-/68 
-/54 
-/93 
-/79 
-/69 
[58] 
RebH variant 3-SS 
(purified) 
 
RebH variant 4-V 
(purified) 
10 
 
 
10 
 
Tryptoline 
 
 
Carvedilol 
Pindolol 
Thenalidine 
Br 
 
 
Cl 
Br 
n.d. [a] [71] 
RebH/ThaI/PyrH 
(combiCLEAs) 150 L-tryptophan Br 100 
[c] [72] 
[a] Enzymatic halogenation yields not determined for these chemoenzymatic cascade reactions. [b] Isolated yields % for the 
three different variants studied (0S/8F/10S). [c] Conversion yield % was 100 for all cases of immobilized Fl-Hals studied. 
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